It was also reported that reduced editing of COPA was implicated in the pathogenesis of HCC and editing of COPAWT may switch it from a tumor-promoting gene to a tumor suppressor by deactivating the PI3K/AKT/mTOR pathway through downregulation of caveolin-1 (CAV1) [20]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.